FDA revisits mercury fillings
A U.S. Food and Drug Administration advisory committee is holding a two-day hearing to re-review the scientific basis for the FDA's conclusion that mercury in amalgam dental fillings is not harmful to patients. The committee initiated the hearings less than 18 months after the federal agency made the decision. Committee members are examining challenges from four consumer and dental groups that say the FDA used flawed science when it set the guidelines for mercury safety levels. Although the FDA noted there will be no vote on this, they may recommend to reverse the decision and send it to the main FDA board for review.
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063